| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Oct 2026 | 22 Oct 2026 |
| To consider and approve the financial results for the period ended September 30, 2026 and other business matters ZOTA: Zota Health Care Limited has submitted to the Exchange the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30, 2026 As Per NSE Announcement Dated On : 28.10.2026 | ||
| Board Meeting | 3 Sep 2026 | 3 Sep 2026 |
| Zota Health Care Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026. | ||
| Board Meeting | 13 Aug 2026 | 6 Aug 2026 |
| Financial Results/Other business matters Zota Health Care Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026. As Per NSE Announcement Dated On : 13.06.2026) | ||
| Board Meeting | 22 May 2026 | 15 May 2026 |
| Financial Results/Dividend/Other business matters Zota Health Care Limited has submitted to the Exchange, the Audited Financial Results for the quarter and year ended March 31, 2026. (As Per NSE Announcement Dated on:22.05.2026) | ||
| Board Meeting | 13 Mar 2026 | 13 Mar 2026 |
| Zota Health Care Limited has informed the Exchange regarding Outcome of Board Meeting held on March 13, 2026. | ||
| Board Meeting | 4 Feb 2026 | 30 Jan 2026 |
| To consider and approve the financial results for the period ended December 31, 2025 and other business matters Zota Health Care Limited has submitted to the Exchange, the financial results for the quarter and nine months ended December 31, 2025. (As Per NSE Announcement Dated on : 04.02.2026) | ||
| Board Meeting | 2 Jan 2026 | 3 Jan 2026 |
| Zota Health Care Limited has informed the Exchange regarding allotment of 107556 equity shares upon conversion of warrants pursuant to Preferential Issue at its meeting held on January 02, 2026. Zota Health Care Limited has informed the Exchange about Intimation of Wholly Owned Subsidiary of the Company to be incorporated in the name of KMHP VENTURES LIMITED. | ||
| Board Meeting | 24 Dec 2025 | 24 Dec 2025 |
| Zota Health Care Limited has informed the Exchange regarding allotment of 602500 equity shares upon conversion of warrants pursuant to Preferential Issue at its meeting held on December 24, 2025. | ||
The company informed that its fund raising committee approved a floor price of ₹1,615.28 per equity share on December 15, 2025.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
